Found 2 hits Enz. Inhib. hit(s) with Target = 'Diacylglycerol O-acyltransferase 1' and Ligand = 'BDBM50438727' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Diacylglycerol O-acyltransferase 1
(Homo sapiens (Human)) | BDBM50438727
(CHEMBL2414654)Show SMILES Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(=O)N4CCOCC4)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(26.47,-50.14,;26.49,-51.7,;25.15,-52.5,;25.18,-54.05,;26.53,-54.81,;27.88,-54.01,;29.1,-54.96,;30.61,-54.6,;31.26,-53.18,;30.57,-51.79,;31.53,-50.57,;30.95,-49.12,;31.9,-47.91,;33.42,-48.13,;34,-49.55,;33.05,-50.76,;34.4,-46.89,;33.81,-45.43,;34.76,-44.22,;36.28,-44.44,;37.25,-43.2,;38.77,-43.42,;39.34,-44.85,;39.75,-42.18,;39.16,-40.72,;40.11,-39.51,;41.63,-39.73,;42.2,-41.16,;41.25,-42.36,;36.85,-45.87,;35.9,-47.07,;29.05,-51.47,;28.68,-49.96,;27.85,-52.45,)| Show InChI InChI=1S/C25H31N5O4/c26-23-22-24(28-16-27-23)34-14-11-30(25(22)32)20-7-5-19(6-8-20)18-3-1-17(2-4-18)15-21(31)29-9-12-33-13-10-29/h5-8,16-18H,1-4,9-15H2,(H2,26,27,28)/t17-,18- | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description
Inhibition of DGAT-1-mediated triglyceride synthesis in human HT-29 cells using [3H]-glycerol as substrate incubated for 1 hr prior to substrate addi... |
Bioorg Med Chem 21: 5081-97 (2013)
Article DOI: 10.1016/j.bmc.2013.06.045
BindingDB Entry DOI: 10.7270/Q26111RG |
More data for this
Ligand-Target Pair | |
Diacylglycerol O-acyltransferase 1
(Homo sapiens (Human)) | BDBM50438727
(CHEMBL2414654)Show SMILES Nc1ncnc2OCCN(c3ccc(cc3)[C@H]3CC[C@H](CC(=O)N4CCOCC4)CC3)C(=O)c12 |r,wU:16.16,wD:19.20,(26.47,-50.14,;26.49,-51.7,;25.15,-52.5,;25.18,-54.05,;26.53,-54.81,;27.88,-54.01,;29.1,-54.96,;30.61,-54.6,;31.26,-53.18,;30.57,-51.79,;31.53,-50.57,;30.95,-49.12,;31.9,-47.91,;33.42,-48.13,;34,-49.55,;33.05,-50.76,;34.4,-46.89,;33.81,-45.43,;34.76,-44.22,;36.28,-44.44,;37.25,-43.2,;38.77,-43.42,;39.34,-44.85,;39.75,-42.18,;39.16,-40.72,;40.11,-39.51,;41.63,-39.73,;42.2,-41.16,;41.25,-42.36,;36.85,-45.87,;35.9,-47.07,;29.05,-51.47,;28.68,-49.96,;27.85,-52.45,)| Show InChI InChI=1S/C25H31N5O4/c26-23-22-24(28-16-27-23)34-14-11-30(25(22)32)20-7-5-19(6-8-20)18-3-1-17(2-4-18)15-21(31)29-9-12-33-13-10-29/h5-8,16-18H,1-4,9-15H2,(H2,26,27,28)/t17-,18- | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description
Inhibition of human full length DGAT-1 expressed in insect sf9 cells using [14C]decanoylCoA as substrate after 1.5 hrs by scintillation spectrometry |
Bioorg Med Chem 21: 5081-97 (2013)
Article DOI: 10.1016/j.bmc.2013.06.045
BindingDB Entry DOI: 10.7270/Q26111RG |
More data for this
Ligand-Target Pair | |
Search and Browse
